MedPath

Lifestyle Modification for Type 2 Diabetes Involving Reduction of After-meal Blood Glucose Elevations

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Behavioral: GEM
Registration Number
NCT02432391
Lead Sponsor
University of Virginia
Brief Summary

The purpose of this study is to determine if a lifestyle modification program (GEM) that focuses on reducing after-meal blood glucose elevations can improve blood glucose control in people with type 2 diabetes. Half of the participants will continue their routine medical care, and half will receive five sessions of GEM in addition to their routine care. The two groups will be assessed using diabetes-relevant medical, behavioral and psychological measures.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
47
Inclusion Criteria
  • Diagnosed with type 2 diabetes within the past 5 years
  • Age >24 and <80 years
  • HbA1c >7.0%
  • Approval of primary care physician to participate
Exclusion Criteria
  • Currently using, or used within the last 3 months, medications that directly lower BG (e.g., insulin, sulfonylureas, glinides, or DPP-4 inhibitors).
  • Currently using, or used within the last 3 months, thiazides at doses above HCTZ 25 mg or equivalent, or loop diuretics above furosemide 20mg or equivalent.
  • Currently pregnant or contemplating pregnancy in the coming year
  • Currently using, or used within the last 3 months, medications that impede weight loss (e.g., prednisone)
  • Having conditions that preclude increasing physical activity, e.g. severe neuropathy, active cardiovascular disease, emphysema, osteoarthritis, stroke.
  • Undergoing cancer treatment
  • History of lactic acidosis
  • Diagnosed with renal impairment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
GEMGEMParticipants receive the GEM (Glycemic load, Exercise, and Monitoring blood glucose) lifestyle modification program and continue their routine medical care for type 2 diabetes.
Primary Outcome Measures
NameTimeMethod
Change from baseline glycosylated hemoglobin at 6 months0 and 6 months

HbA1c

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Virginia

🇺🇸

Charlottesville, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath